# Katie's Requirements Compliance Checklist
## Pre-Meeting Reference Document (Dec 12, 2024)

This document verifies that all analyses comply with the specifications outlined in Katie's email correspondence (Nov 30 - Dec 9, 2024).

---

## ‚úÖ STRUCTURAL REQUIREMENTS (100% Complete)

### 1. Three Technologies Analyzed Separately ‚úÖ
- [x] **Avatar** analyzed in separate models (H1, H2a, H2b, H3)
- [x] **Chatbot** analyzed in separate models (H1, H2a, H2b, H3)
- [x] **Teletherapy** analyzed in separate models (H1, H2a, H2b, H3)
- [x] **No composite outcome** - each technology tested independently

**Katie's requirement (Dec 1):**
> "H1: Self-determination predicts attitudes towards AI for 3 mental health technologies (Avatar, chatbot, teletherapy)"

‚úÖ **Confirmed in:** All notebook headers, model specifications, results tables

---

## ‚úÖ HYPOTHESIS STRUCTURE (100% Complete)

### H1: Main Effects ‚úÖ
**Katie's requirement (Dec 1):**
> "H1: Self-determination predicts attitudes towards AI for 3 mental health technologies (Avatar, chatbot, teletherapy), while controlling for confounders (GAAIS, demographics etc)."

**Completed:**
- [x] Three separate models (Avatar, Chatbot, Teletherapy)
- [x] SDT as predictor in all models
- [x] All confounders controlled (GAAIS, ET, PHQ, SSRPH, age, gender, Country)
- [x] Confounder-first approach implemented
- [x] ŒîR¬≤ reported for SDT contribution

**Status:** ‚úÖ Fully aligned with Katie's framework

---

### H2: Role Moderation ‚úÖ
**Katie's requirement (Dec 1):**
> "H2: Clinical role moderates this relationship x 3 technologies"

**Katie's clarification (Dec 2):**
> "For the role moderation, we should certainly include the USA sample. We can do the analysis on clinician vs patient vs community in the USA sample only and we can do the analysis of clinician vs patient in the Chinese and USA sample combined."

**Completed:**

#### H2a: Combined China + USA ‚úÖ
- [x] Sample: China + USA combined (N‚âà1632, excludes USA community)
- [x] Moderator: `role_binary` (Clinician vs Patient)
- [x] Three technologies tested separately
- [x] Country controlled as covariate
- [x] All confounders included

#### H2b: USA Only ‚úÖ
- [x] Sample: USA only (N‚âà1742)
- [x] Moderator: `role_label_usa3` (Clinician vs Patient vs Community)
- [x] Three technologies tested separately
- [x] All confounders included

**Katie's coding rule (Dec 8):**
> "For the USA sample you can use the clinicians as clinicians (even if they are also patients... which is very common). We can use all patients unless they are also clinicians."

- [x] **Applied:** Clinicians prioritized in coding hierarchy

**Status:** ‚úÖ Fully aligned with Katie's specifications

---

### H3: Country Moderation ‚úÖ
**Katie's requirement (Dec 1):**
> "H3: Country moderates this relationship x3 technologies"

**Completed:**
- [x] Sample: Combined China + USA (N=2227)
- [x] Moderator: Country (China vs USA)
- [x] Three separate models (Avatar, Chatbot, Teletherapy)
- [x] SDT √ó Country interaction tested for each technology
- [x] All confounders controlled
- [x] Simple slopes analysis conducted

**Status:** ‚úÖ Fully aligned with Katie's framework

---

## ‚úÖ METHODOLOGICAL REQUIREMENTS (100% Complete)

### 1. Confounder-First Structure ‚úÖ
**Katie's guidance (Dec 1):**
> "I revised the moderation pipeline so that... I restructured the reporting sequence to first evaluate potential confounders (general AI attitudes, epistemic trust, stigma, symptoms, and demographic controls) before running any moderation models."

**Implementation:**
- [x] **Step 1:** Baseline models with confounders only
- [x] **Step 2:** Add SDT predictor ‚Üí evaluate ŒîR¬≤
- [x] **Step 3:** Add interactions ‚Üí evaluate ŒîR¬≤
- [x] Model comparison approach used throughout

**Evidence:** See all notebook sections labeled "Baseline Model" ‚Üí "Main Effect Model" ‚Üí "Moderation Model"

---

### 2. GAAIS and ET as Covariates (NOT Moderators) ‚úÖ
**Katie's guidance (Dec 1):**
> "Only the theoretically central moderators (culture and clinician vs. patient role) are now framed as focal variables, while trust and general AI attitudes are treated strictly as covariates rather than moderators."

**Implementation:**
- [x] **GAAIS** included as control in all models, NEVER as moderator
- [x] **ET** included as control in all models, NEVER as moderator
- [x] No SDT √ó GAAIS or SDT √ó ET interactions tested
- [x] Treated consistently across all analyses (H1, H2, H3)

**Evidence:** 
- Covariates section in all notebooks explicitly states: "GAAIS and ET treated as covariates, NOT moderators"
- No interaction terms involving GAAIS or ET in any model

---

### 3. Role Variable Operationalization ‚úÖ
**Katie's specifications (Dec 2 & Dec 8):**

‚úÖ **Combined analysis (China + USA):**
> "We can do the analysis of clinician vs patient in the Chinese and USA sample combined"
- [x] Variable created: `role_binary`
- [x] Values: Clinician (0) vs Patient (1)

‚úÖ **USA-only analysis:**
> "We can do the analysis on clinician vs patient vs community in the USA sample only"
- [x] Variable created: `role_label_usa3`
- [x] Values: Clinician / Patient / Community (3 levels)

‚úÖ **Coding priority:**
> "For the USA sample you can use the clinicians as clinicians (even if they are also patients... which is very common)"
- [x] Applied: Clinicians coded as clinicians regardless of patient status

**Evidence:** Exploratory_Data_Analysis.ipynb, Role Harmonization section

---

### 4. Data Quality and Preparation ‚úÖ
- [x] China and USA datasets harmonized
- [x] Multiple imputation applied (MICE algorithm)
- [x] Sample retention: 95% (N=2227/2342)
- [x] All composite scales computed with reliability checks
- [x] Predictor variables grand-mean centered
- [x] Multicollinearity assessed (all VIF<2.0)

---

## ‚úÖ REPORTING REQUIREMENTS (100% Complete)

### Statistical Reporting ‚úÖ
For all models, reported:
- [x] Standardized Œ≤ coefficients
- [x] Standard errors (SE)
- [x] p-values
- [x] 95% Confidence intervals (for H3)
- [x] ŒîR¬≤ (incremental variance explained)
- [x] Effect size interpretation (Cohen's guidelines)
- [x] Sample sizes for each analysis

### Model Diagnostics ‚úÖ
- [x] VIF values reported (multicollinearity check)
- [x] Model fit statistics (R¬≤, adjusted R¬≤)
- [x] F-test results for model comparisons
- [x] Residual diagnostics performed

---

## ‚úÖ DECISION POINTS FROM EMAIL CORRESPONDENCE

### 1. Double Moderation (Dec 1 email) ‚úÖ
**Katie's question:**
> "If both H2 and H3 are significant, maybe we can test a double moderation model?"

**Decision:** ‚úÖ Addressed and resolved
- H2 effects are negligible (ŒîR¬≤ <0.005, mostly p>0.10)
- H3 effects are substantial (ŒîR¬≤ >0.010, all p<0.001)
- **Conclusion:** Triple interaction (SDT √ó Role √ó Country) NOT justified
- **Evidence:** Documented in H2 and H3 completion summaries

**Jackson's update (Dec 9):**
> "Given the very small effects in H2, the double moderation (SDT √ó Role √ó Country) structure does not appear justified."

**Katie's response (Dec 9):**
> "Sounds good, thanks Jackson"

‚úÖ **Status:** Decision confirmed with Katie

---

### 2. Abstract and Report Restructuring (Dec 1 email) ‚úÖ
**Katie's request:**
> "Do you mind restructuring your abstract and your report in line with your structure above (as you summarized in your email)."

**Completed:**
- [x] All notebooks restructured to H1-H2-H3 framework
- [x] Old H4 (mediation) removed from core hypotheses
- [x] Abstract framework prepared (see COMPREHENSIVE_ANALYSIS_REPORT.md)
- [x] Report aligns with email summary

**Katie's confirmation (Dec 1):**
> "The summary in your email text is exactly right."

‚úÖ **Status:** Report structure now matches email summary exactly

---

## üìä RESULTS ALIGNMENT WITH KATIE'S EXPECTATIONS

### Expected Pattern (from Dec 9 email update)
**Jackson's summary:**
> "All analyses for H1, H2, and H3 are now fully completed following your framework:
> - H1 (Main Effects): Completed for all three technologies in separate models with full covariate control.
> - H2 (Role Moderation): Completed both in the Combined sample and in the USA-only sample as you suggested. Effects appear very weak, with ŒîR¬≤ < .005.
> - H3 (Country Moderation): Completed for all three technologies, and the moderation effects are substantial and highly significant across the board (all p < .001)."

**Katie's response:**
> "Sounds good, thanks Jackson"

‚úÖ **Status:** Results pattern confirmed acceptable to Katie

---

## üìù DELIVERABLES FOR MEETING

### Completed Notebooks ‚úÖ
1. [x] **Exploratory_Data_Analysis.ipynb**
   - Data harmonization and preparation
   - Role variable operationalization
   - Imputation workflow
   - ‚úÖ Completion summary added (Dec 11, 2024)

2. [x] **H1_Main_Effect_SDT_Acceptance.ipynb**
   - Three separate technology models
   - Confounder-first approach
   - ŒîR¬≤ reporting
   - ‚úÖ Completion summary added (Dec 11, 2024)

3. [x] **H2_Moderation_SDT_Acceptance.ipynb**
   - H2a: Combined China+USA (Clinician vs Patient)
   - H2b: USA only (3-level role)
   - Both analyses complete
   - ‚úÖ Completion summary added (Dec 11, 2024)

4. [x] **H3_Cross_Cultural_Moderation.ipynb**
   - Country moderation for all 3 technologies
   - Simple slopes analysis
   - Interaction plots
   - ‚úÖ Completion summary added (Dec 11, 2024)

### Documentation ‚úÖ
5. [x] **COMPREHENSIVE_ANALYSIS_REPORT.md**
   - Complete methodology documentation
   - All results integrated
   - Manuscript recommendations
   - Prepared specifically for meeting

6. [x] **KATIE_REQUIREMENTS_CHECKLIST.md** (this document)
   - Point-by-point verification
   - Email correspondence tracking
   - Quick reference for meeting

---

## üéØ MEETING READINESS (Dec 12, 2024, 8:00 PM EST)

### All Requirements Met ‚úÖ
- [x] **Analytic framework:** 100% aligned with Katie's specifications
- [x] **Sample structure:** Correct for each hypothesis
- [x] **Role coding:** Exactly as specified
- [x] **Control variables:** GAAIS/ET as covariates only
- [x] **Technologies:** All three tested separately
- [x] **Reporting:** Complete with effect sizes

### Key Messages for Meeting ‚úÖ
1. ‚úÖ All analyses complete and aligned with framework
2. ‚úÖ H1 shows technology-specific patterns (partial support)
3. ‚úÖ H2 shows negligible role moderation (not supported)
4. ‚úÖ H3 shows strong country moderation (strongly supported)
5. ‚úÖ Culture is the key moderator, not role
6. ‚úÖ Ready to discuss manuscript structure and next steps

### Questions Prepared for Katie üìã
1. How should we frame H2 null findings in the manuscript?
2. Theoretical interpretation of cross-cultural patterns (H3)?
3. The teletherapy negative effect - implications for SDT theory?
4. Abstract emphasis: "culture as primary moderator"?
5. Timeline and next steps for full paper draft?
6. Interest in SPR Osaka 2026 presentation - submission timeline?

---

## üìß EMAIL CORRESPONDENCE SUMMARY

### Nov 30-Dec 1: Framework Clarification
- Katie confirms H1-H2-H3 structure is correct
- Requests report restructuring to match
- Asks about double moderation if both H2 and H3 significant

### Dec 2: Role Specification
- Katie clarifies two separate role analyses needed
- H2a: Combined China+USA (Clinician vs Patient)
- H2b: USA only (3-level role)
- Coding rule: Clinicians prioritized

### Dec 8: Meeting Confirmation
- Katie confirms Thursday 8pm EST / Friday 9am China time
- Jackson to share updated results before meeting

### Dec 9: Results Preview
- Jackson shares H1/H2/H3 completion status
- Reports H2 weak (ŒîR¬≤<.005), H3 strong (all p<.001)
- Katie confirms readiness for meeting

**All correspondence requests addressed and implemented** ‚úÖ

---

## ‚úÖ FINAL COMPLIANCE VERIFICATION

### Framework Alignment: 100% ‚úÖ
Every element specified by Katie has been implemented exactly as described.

### Methodological Rigor: 100% ‚úÖ
All analyses use appropriate statistical tests, diagnostics, and reporting standards.

### Documentation Completeness: 100% ‚úÖ
All notebooks contain summary sections. Comprehensive report prepared.

### Meeting Readiness: 100% ‚úÖ
All deliverables complete. Questions prepared. Ready to discuss next steps.

---

**Status: READY FOR MEETING**

All analyses comply fully with Katie's requirements. The pipeline is complete, documented, and ready for manuscript preparation.

*Last updated: December 11, 2024*
